Editorial Board ::: MicroRNA

ISSN: 2211-5374 (Online)
ISSN: 2211-5366 (Print)


Volume 6, 3 Issues, 2017


Download PDF Flyer




MicroRNA

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Alberto Izzoti
University of Genoa
Genoa
Italy


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Editorial Board

Editor-in-Chief:

Alberto Izzoti (Biography
Alberto Izzoti

Dr. Alberto Izzotti is MD, Specialist in Hygiene and Preventive Medicine, PhD in Toxicology, Full-Professor at the School of Medicine of the University of Genoa, Italy, Director of UOC Mutagenesis and Cancer Prevention at the National Research Institute for Cancer Research San Martino Hospital, Genoa, Italy. He has 30 years of experience in research devoted to the study of chronic-degenerative diseases, molecular medicine, cancer prevention, human biomonitoring, microarray analysis of gene, microRNA, and protein expression. Author of more than 200 papers. He was Principal Investigator of Research Projects supported by many international institutions including the US National Cancer Institute.

)

University of Genoa
Genoa
Italy



Co-Editor:

Xiaofeng Charles Zhou (Biography
Xiaofeng Charles Zhou

Dr. Xiaofeng Charles Zhou received his PhD in Biochemistry from Boston University and a M.S. degree in Software Engineering from Brandeis University. He did his Post-Doctoral training in human genetics and second Post-Doctoral training in cancer genomics at Boston University and University of California in Los Angeles (UCLA), respectively. He has published more than 90 journal articles, review articles, and book chapters. Dr. Zhou is currently an Associate Professor at University of Illinois at Chicago. He is also a Visiting Professor at Sun Yat-sen University, China.

)

Center for Molecular Biology of Oral Diseases
College of Dentistry
UIC Cancer Center
University of Illinois at Chicago
Chicago, IL
USA


Associate Editors:

W.W. Au
Shantou University Medical College
Shantou
China

A. Russo (Biography
A. Russo

Dr. Aniello Russo is an Associate Professor of Molecular Biology at Second University of Naples, Caserta, Italy. He received his Ph.D. in Biochemistry in 1993, at Federico II University of Naples, and Post-Doctoral training at Harvard University, where he was also appointed Instructor. Dr. Russo’s research is dedicated to microRNAs, focusing on their role in human pathologies, such as viral hepatitis, cancer and heart failure. In addition to research and teaching, from 2009 to 2015 he served the Faculty of Sciences of Second University of Naples as President of the Bachelor and Master of Science programs in Biology.

)

Second University of Naples
Caserta
Italy

W. Tam
Weill Cornell Medical College
New York, NY
USA

Y.H. Wang (Biography
Y.H. Wang

Yonghua Wang is a full professor in Systems Pharmacology at Northwest A &F University, China and is a visiting professor at Politecnico di Torino, Italy. Prof. Wang has devoted his research to systems pharmacology, particularly developing methods to understand mechanisms of action for herbs and plant-origin drug discovery by systems biology methods. He is the author or coauthor of 135 scientific papers, book chapters and 17 abstracts. He has applied for 9 patents for new drugs and 3 of them have been authorized. He serves as the Associate Editor for the international journal ‘microRNA’ and the member of Journal of Bioequivalence & Bioavailability.He serves as editor of Journal of Bioinformatics, Computational and Systems Biology.

)

Northwest A & F University
Yangling
China

A. Masoudi-Nejad
Tehran University
Tehran
Iran

N. Saini
Institute for Genomics and Integrative Biology
Delhi
India

H. Tang (Biography
H. Tang

Dr. Tang obtained his Medical Doctor Degree and Ph.D. in Pathogen Biology from Tianjin Medical University, and gained postdoctoral training in Harvard University and HHMI. He was a faculty member in Harvard Medical School and Fudan University. Currently Dr. Tang is a Professor and Chair of Tianjin Life Science Research Center and Department of Pathogen Biology, Tianjin Medical University. Dr. Tang has focused on the regulation of non-coding RNA on tumorigenesis and viral proliferation. He has published more than 100 research articles and served as an editor of more than 10 journals.

)

Tianjin Medical University
Tianjin
China

M. Yamakuchi
Kagoshima University
Kagoshima
Japan

S.D. Meng (Biography
S.D. Meng

Dr. Songdong Meng obtained Ph.D degree in Microbiology from Shenyang Institute of Applied Ecology of Chinese Academy of Sciences (CAS). Currently he is a professor in Institute of Microbiology of CAS, and also in College of Life Sciences in University of CAS. He has published more than 40 scientific papers, and is a named inventor of 10 issued China patents.

)

Institute of Microbiology of CAS
Beijing
China

T. Sun
Cornell University Weill Medical College
New York, NY
USA

P. Trivedi (Biography
P. Trivedi

Dr. Pankaj Trivedi obtained his doctorate from Karolinska Institute, Sweden in 1995. Currently, he is Associate Professor at faculty of Medicine, La Sapienza University in Rome, Italy. Over the last 30 years, his main interest has been to study the role Epstein-Barr virus in pathogenesis of B cell lymphomas. Dr. Trivedi’s research also include the role of cellular microRNA in EBV induced transformation. He has authored over 60 papers in this field.

)

La Sapienza University
Rome
Italy

A.M. Yu
UC Davis School of Medicine
Sacramento, CA
USA


Regional Editors:

A. van den Berg (Biography
A. van den Berg

Dr. Anke van den Berg is a molecular biologist with a long standing interest in cancer research. She obtained her PhD (cum laude) on “The involvement of chromosome 3 deletions in renal cell carcinoma” in 1996. After her PhD, Dr. van den Berg moved to the field of B cell lymphoma with a special interest in microRNAs. In 2009 she was appointed as professor in Molecular pathogenesis of malignant B cell lymphoma at the Department of Pathology & Medical Biology. She has obtained multiple research grants of the Dutch Cancer Society (KWF), NWO, SKOG, Vanderes and others. She has published over 170 papers in international peer reviewed journals.

)

University of Groningen
University Medical Center Groningen
Groningen
The Netherlands

M.P. Gantier (Biography
M.P. Gantier

Dr Gantier obtained his Ph.D. in Medicine from University College Dublin (Ireland) before moving to Australia in 2006. After several years of postdoctoral studies with Prof. Bryan Williams, Dr Gantier was promoted in 2015 to the position of laboratory head, at the Hudson Institute of Medical Research. In the past 10 years, Dr Gantier has published more than 40 scientific publications, with a focus on the sensing of nucleic acids by the innate immune system, and its modulation by microRNAs. His laboratory is currently investigating the mechanisms regulating the stability of microRNAs in mammalian cells.

)

Monash University
Melbourne
Australia

R. Biswas (Biography
R. Biswas

Roopa Biswas, earned a PhD in Biochemistry from Ohio State University (OSU) in 1997. She continued at OSU as a Research Associate where she studied structural features of RNA by X-ray crystallography and also applied biochemical biophysical structure mapping techniques for RNA-protein complexes. In 2001, she was recruited to the position of Project Scientist in the Department of Immunology at the Cleveland Clinic Foundation. At the Cleveland Clinic Foundation, she used her expertise in RNA protein interaction to investigate the mechanisms through which sequences in unstable mRNAs control the process of mRNA degradation in inflammatory systems. She remained at the Cleveland Clinic until July 2005, when she was recruited to the Graduate School of Nursing (GSN), Uniformed Services University of the Health Sciences (USUHS). Subsequently she was recruited to the School of Medicine, Department of Anatomy, Physiology and Genetics, USUHS in 2013.

)

The Uniformed Services
University of Health Sciences
Bethesda
MD
USA

R. Rota
Ospedale Pediatrico Bambino Gesu' IRCCS
Roma
Italy

A.E. Erson-Bensan (Biography
A.E. Erson-Bensan

Dr. Erson-Bensan graduated from Biological Sciences Department of METU (ODTU), Ankara. She obtained her Ph.D. in Human Genetics from the University of Michigan, Ann Arbor. Currently, Dr. Erson-Bensan is a faculty member at METU (ODTU) in Ankara. Her research is focused on understanding the roles of mRNA 3’ UTRs in gene regulation in cancer cells. She has published >20 journal articles and book chapters. Dr. Erson-Bensan received numerous awards, including the AACR-WICR Brigid G. Leventhal Scholar Award, Cancer Research Award by Molecular Cancer Research Association of Turkey (MOKAD) and Research Stimulus Award by the Parlar Foundation.

)

Middle East Technical University (METU)
Ankara
Turkey

B. Zhang (Biography
B. Zhang

Dr. Zhang, obtained his MS in chemistry from Fordham University and Ph.D. in Organic Chemistry from Columbia University and did his postdoctoral research in RNA field at the University of Colorado at Boulder. Currently he is a professor of RNA chemical biology at the Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, the founder of Guangzhou RiboBio Co. He has published more than 60 scientific papers and more than 20 patents.

)

Guangzhou Institutes of Biomedicine and Health (CAS)
Guangzhou
China


Editorial Board Members:

R. Abounader
University of Virginia
Charlottesville, VA
USA

A.G. Bader (Biography
A.G. Bader

Dr. Andreas Bader currently serves as Vice President, Translational Research & Development, at Mirna Therapeutics, a biopharmaceutical company focused on the development of microRNA-based oncology therapeutics. Previously, Dr. Bader led the microRNA therapeutics program at Asuragen until it was spun off as Mirna in 2007. Dr. Bader held a faculty position at The Scripps Research Institute, La Jolla, California, where he also completed his postdoctoral training, focusing on molecular mechanisms of cancer and the identification of novel cancer drug targets. Dr. Bader received his M.S. in biology and his Ph.D. in biochemistry from the University of Innsbruck, Austria.

)

Mirna Therapeutics, Inc.
Austin, TX
USA

A. Carnero
Biomedicine Institute of Sevilla- IBiS/HUVR
Sevilla
Spain

W.J. Chen (Biography
W.J. Chen

Dr. Wei J. Chen, a physician (MD, National Taiwan University, 1984) and epidemiologist (ScD, Harvard School of Public Health, 1992), currently is Dean of College of Public Health, National Taiwan University. His research focuses on the epidemiological, clinical, neuropsychological, and molecular genetic studies of mental disorders, using endophenotype-based approaches. In addition, his lab has embarked on the gene expression research and identified a seven-microRNA signature as potential peripheral biomarkers for schizophrenia. He has received several awards, including Outstanding Research Award of National Science Council, and has been Distinguished Professor of National Taiwan University since 2007.

)

National Taiwan University
Taipei
Taiwan

C. Di Pietro (Biography
C. Di Pietro

Cinzia Di Pietro is Associate Professor of Biology and Genetics at the University of Catania, School of Medicine, Department of Biomedical and Biotechnological Sciences. She graduated in Biological Science and obtained the PhD in Molecular Biology at Bari University. She is the Head of Laboratory of Biology of Reproduction. Specifically, her group carry on studies on transcriptome alteration of oocytes and somatic follicular cells in relation to female reproductive aging. Her research group purified, for the first time, exosomes from human follicular fluid, identifying their microRNA cargo and, recently, identifying miRNA expression changes in reproductive aging.

)

University of Catania
Catania
Italy

K. Ghoshal (Biography
K. Ghoshal

Dr. Kalpana Ghoshal is an Associate Professor of the Department of Pathology at the Ohio State University. She has nearly 30 years of experience in cancer research aimed to understand molecular basis of hepatocellular cancer, the most prevalent liver cancer. Currently, research in my lab focuses on elucidating the role of microRNAs in liver biology and the consequence of their deregulation in various liver disease including cancer.

)

The Ohio State University
Columbus, OH
USA

P.J. Hurd
Queen Mary University of London
London
UK

A.E. Kerscher
Eastern Virginia Medical School
Norfolk, VA
USA

M.L. Kuo (Biography
M.L. Kuo

Dr. Min-Liang Kuo is a Professor in the Institute of Biological Chemistry at National Taiwan University. Dr. Kuo’s research mainly focused on elucidating the underlying mechanism of tumor development and progression, including phenotypic intra-tumor heterogeneity and epigenetic alteration in cancer stem cells. He has published more than 150 scientific publications, 5 patents, and sixteen of his publications were cited over 100 times. He also was a visiting professor at the Department of Molecular Oncology of MD Anderson Cancer Center in 2006.

)

National Taiwan University Hospital
Taipei
Taiwan

R.-J. Lin (Biography
R.-J. Lin

RJL identified the bacterial repetitive rhs elements with Charles Hill at Penn State-Hershey, and developed and characterized yeast pre-mRNA splicing extracts and spliceosome with John Abelson at Caltech and later as assistant professor at UT-Austin. Now as Professor and Associate Dean at City of Hope, his lab discovered catalytic magnesium in U6 snRNA and augmented the RNA-centric view of the spliceosome, identified alternatively spliced variants in breast cancer using oligo-microarray, investigated splicing abnormality caused by mutant myelodysplastic syndrome proteins, generated and characterized microRNA or spliceosome mutations using TALEN and crispr/Cas9, and engineered a microRNA-targeting sgRNA library for functional screening.

)

City of Hope Beckman Research Institute
Duarte, CA
USA

R. Natarajan
Beckman Research Institute of City of Hope
Duarte, CA
USA

G. De Petro (Biography
G. De Petro

Giuseppina De Petro, Full Professor of Applied Biology and Molecular Genetics at the Faculty of Medicine of the University of Brescia, Brescia, Italy. The main courses are: General Biology and Genetics for Medical Students, Biology and Genetics applied to dentistry for Dental students, Cellular and Tissue Therapies for Medical Biotechnologists; non-coding RNAs and epigenetics for PhD students in Molecular Genetics, Biotechnologies and Experimental Medicine. She is a group leader working at the Division of Biology and Genetics, Department of Molecular and Translational Medicine, Brescia and developing research lines on RNA interference, microRNAs and epigenetics. Her studies led to the experimental validation of miR-23b as negative coregulator of urokinase and MET; now miR-23b is studied as therapeutic tool for human hepatocellular carcinoma and as biomarker of conventional anticancer treatments.

)

University of Brescia
Brescia
Italy

E.A. Ratovitski (Biography
E.A. Ratovitski

Dr. Edward Ratovitski obtained his Ph.D. Degree in Molecular Biology and Cancer Biology (1979) from the N.N. Petrov Cancer Research Institute (Leningrad, Soviet Union). Currently Dr. Ratovitski is an Adjunct Professor in the Head and Neck Cancer Research Division of the Johns Hopkins University School of Medicine (Baltimore, MD, USA) and the Department of Mechanical and Aerospace Engineering, George Washington University (DC, USA). He has published more than 136 scientific publications, and is a named inventor of five issued US patents. Dr. Ratovitski is an Editorial Board Member of the MicroRNA journal published by Bentham Science Publishers.

)

Johns Hopkins University
Baltimore, MD
USA

H. Ruohola- Baker
University of Washington
Seattle, WA
USA

V.S. Spiegelman
University of Wisconsin
Madison, WI
USA

E. Wang
University of Louisville
Louisville, KY
USA

P.-C. Yang (Biography
P.-C. Yang

Dr. Yang is the President of National Taiwan University (NTU) and Professor in the Department of Internal Medicine, NTU College of Medicine. His major research interests are pulmonary and critical care medicine, molecular and cellular biology, lung cancer genomics and personalized cancer therapy. He is leading the translational research and implementation of precision therapy for lung cancer in Taiwan. His research group identified novel genes and pathways that associated with lung cancer progression. They identified specific gene expression and microRNA biomarkers that might be beneficial for precision therapy of lung cancer patients.

)

National Taiwan University
Taipei
Taiwan

M. Öhman
Stockholm University
Stockholm
Sweden

A. Arcaro (Biography
A. Arcaro

Alexandre Arcaro is a group leader at Bern University Hospital in Switzerland. He graduated in biology at the University of Lausanne (Switzerland) in 1992 and obtained a Ph.D. in natural sciences from the University of Fribourg (Switzerland) in 1995. He was then a postdoctoral fellow at the Ludwig Institute for Cancer Research, University College London, United Kingdom, from 1996 to 1997 and at the Ludwig Institute for Cancer Research, Lausanne Branch, from 1998 to 2000. From 2000 to 2003 he was then a lecturer at Imperial College Faculty of Medicine, London, United Kingdom. He was a group leader at the University Children’s Hospital Zurich, Switzerland, from 2003 to 2009. His research work is focused on the study of receptor tyrosine kinase signaling and PI3K isoforms in human cancer.

)

Bern University Hospital
Bern
Switzerland

B. Berkhout (Biography
B. Berkhout

Ben Berkhout obtained his PhD in 1986 at Leiden University, performed postdoctoral research at the Harvard Medical School and at the National Institutes of Health, Bethesda (1989-1991). He initiated a molecular virology research line at the Academic Medical Center of the University of Amsterdam in 1991, became Head of the Laboratory of Experimental Virology and was appointed Professor of Human Retrovirology in 2002. Ben Berkhout has published over 500 peer-reviewed manuscripts on various topics concerning HIV-1 replication, virus evolution, virus discovery, new antiviral therapeutic strategies (RNA interference, CRISPR-Cas) and HIV-1 vaccine design.

)

Center for Infection and Immunity Amsterdam
Amsterdam
The Netherlands

C. Chen
Life Technologies Corporation
Foster City, CA
USA

W.C. Cho (Biography
W.C. Cho

Dr William Cho is a Biomedical Scientist in Queen Elizabeth Hospital. His main research interests have been focusing on cancer studies utilizing high-throughput technologies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. He is a Guest Professor of a number of Universities. Dr Cho has published over 250 peer-reviewed papers (Lancet Oncology, Clinical Cancer Research, Clinical Chemistry, Annual Oncology, etc) covering cancer biomarkers, proteomics, microRNAs, Chinese medicine and plenty of books including "MicroRNAs in cancer translational research", "An omics perspective on cancer research", "Supportive cancer care with Chinese medicine", etc. These papers have received >7,000 citations.

)

Queen Elizabeth Hospital
Kowloon
Hong Kong

T.S. Elton
The Ohio State University
Columbus, OH
USA

T. Hohn
University of Basel
Basel
Switzerland

H. Jiang
Virginia Tech
Blacksburg, VA
USA

S.A. Khan
University of Pittsburgh
Pittsburgh, PA
USA

Y. Li
University of Louisville
Louisville, KY
USA

M. Malumbres
Spanish National Cancer Research Centre CNIO
Madrid
Spain

B. Ning (Biography
B. Ning

As a Senior Research Biologist at the US FDA, Dr. Baitang Ning is responsible for leading a research team focused on molecular pharmacology and toxicology in the application of personalized medicine. He has designed, developed and established in silico, in vivo, in vitro and molecular approaches to evaluate genetic and epigenetic mechanisms for pharmacological and toxicological effects involving drug metabolizing enzymes and drug targeting enzymes. The results of his work provide an enhanced mechanistic understanding of drug toxicity and efficacy. Dr. Ning’s research efforts have resulted in 80+ peer-reviewed research articles or book chapters, which have been cited 4000+ times.

)

Food and Drug Administration (FDA)
Jefferson, AR
USA

A. Postigo (Biography
A. Postigo

Dr. Postigo is a ICREA Professor of Life and Medical Sciences at the IDIBAPS Research Institute (Barcelona, Spain). He has over 20 years of research experience. Dr Postigo is also Adjunct Visiting Professor at the J Brown Cancer Center at the University of Louisville (KY, USA). His work focuses on the role of ZEB transcription factors in cell differentiation and cancer.

)

University of Barcelona School of Medicine
Barcelona
Spain

R. Regazzi (Biography
R. Regazzi

Romano Regazzi earned a PhD in Biochemistry at the University of Basel, Switzerland in 1987. He is currently full professor and vice-director of the Medical School at the University of Lausanne, Switzerland. The research of Dr. Regazzi is focused on the definition of the molecular mechanisms controlling pancreatic beta-cell functions under normal and pathophysiological conditions. During the last few years his group identified different non-coding RNAs involved in the regulation of beta-cell functions and in the development of Type 1 and Type 2 diabetes. Dr. Regazzi has authored more than 100 scientific publications in peer-reviewed journals.

)

University of Lausanne
Lausanne
Switzerland

H.J.I. Sampen (Biography
H.J.I. Sampen

Dr. Hee-Jeong Im Sampen is a Professor with a primary appointment in the Department of Biochemistry, and joint appointments in the Departments of Internal Medicine (Rheumatology Section) and Orthopedic Surgery. She also holds an appointment at the Jesse Brown Veterans Affairs (VA) Medical Center as well as at the Department of Bioengineering, University of Illinois at Chicago (UIC).

Dr. Im-Sampen has been employed in academic medicine for the past over 20 years where she has taught extensively, published over 110 full-length peer reviewed papers and book chapters and over 250 research abstracts in the fields of skeletal biology focused on age- or injury-related joint disorder like knee osteoarthritis (OA), intervertebral disc degeneration and associated knee joint pain and low back pain.

)

Rush University Medical Center
Chicago, IL
USA

G.P. Studzinski
UMDNJ- New Jersey Medical School
Newark, NJ
USA

S.M. Wang (Biography
S.M. Wang

Dr. San Ming Wang was trained in Swiss Institute for Experimental Cancer Research (M.D.), did his postdoctoral in Northwestern University and University of Chicago. His study is focused on genomics using next-generation sequencing and bioinformatics approaches. He has worked on the areas of transcriptomics, genome structure variation, and genetic predisposition in familial breast cancer.

)

University of Nebraska Medical Center
Omaha, NE
USA

B. Zhang
East Carolina University
Greenville, NC
USA

C.D. Atreya (Biography
C.D. Atreya

Dr. Atreya is the Associate Director for Research for the Office of Blood Research and Review at the Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration. He has been with FDA for over 23 years with regulatory expertise. Dr. Atreya’s research expertise includes microbiology, cell biology and development of novel pathogen reduction concepts and product safety biomarkers for stored blood cells. Dr. Atreya has authored over 70 peer-reviewed scientific publications and wrote several book chapters.

)

U.S. Food and Drug Administration
Rockville, MD
USA

M.J. Cairns
The University of Newcastle
Newcastle, NSW
Australia

J.W. Chen (Biography
J.W. Chen

Dr. Chen received his Ph.D. degree in Life Science from National Defense Medical Center, Taiwan. Dr. Chen had served as the director of Institute of Biomedical Sciences, Institute of Medical Technology, and Research Center for Translational Medicine in National Chung Hsing University. Currently, Dr. Chen is the Distinguished Professor at National Chung Hsing University and also the chairman of Taiwan Genomics and Genetics Society. He has published more than 100 scientific articles and obtained 12 patents. Dr. Chen has dedicated his academic career in interdisciplinary research, spanning mechanisms of cancer metastasis, gene signature discovery, anti-cancer drugs, and bioinformatics.

)

National Chung-Hsing University
Taichung
Taiwan

H.A. Coller
Princeton University
Princeton, NJ
USA

I.M. Ghobrial
Dana-Farber Cancer Institute/Harvard Medical School
Boston, MA
USA

H.-Da Huang
National Chiao Tung University
HsinChu
Taiwan

J. Ju (Biography
J. Ju

Jingfang Ju, Ph.D. is the Co-Director of Translational Research Laboratory at Stony Brook University and Professor in Pathology. He received his Ph.D. in Biochemistry/Molecular biology from the University of Southern California. He was a postdoctoral fellow at the Yale Cancer Center of Yale University School of Medicine. Currently Dr. Ju is leading a translational research program at Stony Brook University School of Medicine focusing on elucidating the molecular mechanism of translational control mediated by microRNAs in cancer and cancer stem cell chemoresistance. He has published over 85 manuscripts and with several patents on microRNAs as biomarker and therapeutic molecules in cancer. The ultimate goal is to improve clinical management of gastrointestinal cancer outcome by using miRNA based precision medicine.

)

The State University of New York at Stony Brook
Stony Brook, NY
USA

R.C. Kukreja
Virginia Commonwealth University
Richmond, VA
USA

Z. Liang (Biography
Z. Liang

Zhongxing Liang, Ph.D., is Assistant Professor of Department of Radiology and Winship Cancer Institute, Emory University. Dr. Liang received his Ph. D. degree from the University of the Mediterranean Aix-Marseille II, France. Dr. Liang’s primary research interesting is to investigate the mechanisms of microRNA involvement in multidrug resistance and metastasis of tumor cells. He is interested in drug discovery for targeted molecular imaging and therapy of cancer. Dr. Liang has authored more than 90 publications, 3 patents, and 3 books.

)

Emory University School of Medicine
Atlanta, Georgia
USA

Y.-Y. Mo
University of Mississippi Medical Center
Jackson, MS 39216
USA

K. Ono
Kyoto University
Kyoto
Japan

P. Provost
Université Laval
Québec, QC
Canada

A.M. Roccaro
Harvard Medical School
Boston, MA
USA

Y. Shi
Beckman Research Institute of City of Hope
Duarte, CA
USA

N. Tran
University of Technology
Sydney
Australia

Y. Xi (Biography
Y. Xi

Dr. Yaguang Xi is the Professor and Vice Chair for Research at the Department of Genetics, Louisiana State University Health Science Center. He received his PhD degree from the Peking University in China and completed his postdoctoral trainings in the International Agency for Research on Cancer (France) and the University of South Alabama Mitchell Cancer Institute. Dr. Xi’s research is focusing on microRNA and cancer biology and cancer chemoprevention. His research programs are funded by the National Health Institutes and American Cancer Society. Dr. Xi has authored over 65 publications and is the inventor for a US patent. He is serving numerous journals and funding agencies as editorial board members and ad-hoc reviewers.

)

University of South Alabama
Mobile, Al
USA

A.J. van Zonneveld (Biography
A.J. van Zonneveld

Dr. Anton Jan van Zonneveld is professor of Experimental Vascular Medicine at the Department of Medicine at the Leiden University Medical Center, Leiden the Netherlands. A molecular biologist by training (University of Leiden) he received his PhD at the University of Amsterdam (Prof dr. P. Borst, Co-promotor Prof. H. Pannekoek) and postdoctoral training at the Research Institute of Scripps Clinic, La Jolla, California, USA. Dr. van Zonneveld is currently head of the Einthoven Laboratory for Experimental Vascular Medicine at the LUMC. Dr van Zonneveld has published over 140 peer reviewed papers mostly related to vascular biology and posttranscriptional control of the vascular response to injury.

)

Leiden University Medical Center
Leiden
The Netherlands


Associate Editorial Board Members:

E. Anastasiadou (Biography
E. Anastasiadou

Eleni Anastasiadou received her Ph.D. from La Sapienza, University of Rome, Italy and focused on the interactions of cellular miRNAs with Epstein Barr Virus latent proteins in lymphoma. Her pioneering work led to identification how viral proteins subvert cellular miRNAs and contribute to cancer. Currently she is examining the role of miRNAs in regulating immune responses to hematological cancers. She has developed 3D microfluidic chip based platforms for drug delivery to test therapeutic potential of miRNAs in cancers and tissue repair. Her principle interest is in identifying novel translational approaches for RNA aided cancer immunotherapy at Beth Israel Deaconess Medical Center/Harvard Medical School.

)

Institute for RNA Medicine
Boston, MA
USA












Advertisement

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science